ACTIVE BIOTECH (BTPC.SG)
ACTIVE BIOTECH (BTPC.SG) operates in Diversified Metals & Mining.
ACTIVE BIOTECH (BTPC.SG) (BTPC) - Total Assets
Latest total assets as of September 2024: €14.90 Million EUR
Based on the latest financial reports, ACTIVE BIOTECH (BTPC.SG) (BTPC) holds total assets worth €14.90 Million EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ACTIVE BIOTECH (BTPC.SG) - Total Assets Trend (2016–2023)
This chart illustrates how ACTIVE BIOTECH (BTPC.SG)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ACTIVE BIOTECH (BTPC.SG) - Asset Composition Analysis
Current Asset Composition (December 2023)
ACTIVE BIOTECH (BTPC.SG)'s total assets of €14.90 Million consist of 87.9% current assets and 12.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 82.2% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €245.00K | 0.6% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how ACTIVE BIOTECH (BTPC.SG)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ACTIVE BIOTECH (BTPC.SG)'s current assets represent 87.9% of total assets in 2023, an increase from 20.5% in 2016.
- Cash Position: Cash and equivalents constituted 82.2% of total assets in 2023, up from 18.8% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 0.6% of total assets.
ACTIVE BIOTECH (BTPC.SG) Competitors by Total Assets
Key competitors of ACTIVE BIOTECH (BTPC.SG) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €15.07 Billion |
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN
|
Germany | €7.86 Billion |
|
PRICELINE.COM
BE:PCE1
|
Germany | €27.98 Billion |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1
|
Germany | €27.98 Billion |
|
MURPHY USA
BE:1MU
|
Germany | €4.40 Billion |
|
RESMED (RME.SG)
STU:RME
|
Germany | €7.22 Billion |
|
DIOS EXPLORATIONS
BE:BFM
|
Germany | €7.25 Million |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
Germany | €25.76 Billion |
ACTIVE BIOTECH (BTPC.SG) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - ACTIVE BIOTECH (BTPC.SG) generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - ACTIVE BIOTECH (BTPC.SG) is currently not profitable relative to its asset base.
ACTIVE BIOTECH (BTPC.SG) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.93 | 0.91 | 5.71 |
| Quick Ratio | 0.93 | 0.91 | 5.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-800.00K | € -900.00K | € 52.59 Million |
ACTIVE BIOTECH (BTPC.SG) - Advanced Valuation Insights
This section examines the relationship between ACTIVE BIOTECH (BTPC.SG)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -13.6% |
| Total Assets | €44.05 Million |
| Market Capitalization | $36.50 USD |
Valuation Analysis
Below Book Valuation: The market values ACTIVE BIOTECH (BTPC.SG)'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: ACTIVE BIOTECH (BTPC.SG)'s assets decreased by 13.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for ACTIVE BIOTECH (BTPC.SG) (2016–2023)
The table below shows the annual total assets of ACTIVE BIOTECH (BTPC.SG) from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €44.05 Million | -13.64% |
| 2022-12-31 | €51.01 Million | -10.21% |
| 2021-12-31 | €56.80 Million | +76.66% |
| 2020-12-31 | €32.16 Million | -51.97% |
| 2019-12-31 | €66.95 Million | -77.86% |
| 2018-12-31 | €302.43 Million | -0.45% |
| 2017-12-31 | €303.81 Million | -26.42% |
| 2016-12-31 | €412.88 Million | -- |